loadpatents
Patent applications and USPTO patent grants for Siddiqui; M. Arshad.The latest application filed is for "inhibitors of cyclin-dependent kinase 7 (cdk7)".
Patent | Date |
---|---|
Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases Grant 11,325,903 - Siddiqui , et al. May 10, 2 | 2022-05-10 |
Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases Grant 11,192,887 - Siddiqui , et al. December 7, 2 | 2021-12-07 |
Heteroaromatic compounds useful for the treatment of proliferative diseases Grant 11,040,957 - Ciblat , et al. June 22, 2 | 2021-06-22 |
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20210061803 - Ciblat; Stephane ;   et al. | 2021-03-04 |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,906,889 - Gray , et al. February 2, 2 | 2021-02-02 |
Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,865,206 - Ciblat , et al. December 15, 2 | 2020-12-15 |
Substituted Pyrazole and Pyrrole Compounds and Methods for Using Them for Inhibition of Initiation of Translation and Treatment App 20200261424 - Siddiqui; M. Arshad ;   et al. | 2020-08-20 |
Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto Grant 10,537,558 - Siddiqui , et al. Ja | 2020-01-21 |
Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,519,135 - Sprott , et al. Dec | 2019-12-31 |
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20190337940 - Ciblat; Stephane ;   et al. | 2019-11-07 |
Heteroaromatic Compounds Useful For The Treatment Of Proliferative Diseases App 20190292167 - Ciblat; Stephane ;   et al. | 2019-09-26 |
Heteroaromatic Compounds Useful For The Treatment Of Proliferative Diseases App 20190241541 - Ciblat; Stephane ;   et al. | 2019-08-08 |
Polycyclic Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20190031642 - Gray; Nathanael ;   et al. | 2019-01-31 |
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20180319772 - Sprott; Kevin ;   et al. | 2018-11-08 |
Substituted Pyrazole and Pyrrole Compounds and Methods for Using Them for Inhibition of Initiation of Translation and Treatment of Diseases and Disorders Relating Thereto App 20180311218 - Siddiqui; M. Arshad ;   et al. | 2018-11-01 |
Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,106,526 - Sprott , et al. October 23, 2 | 2018-10-23 |
Inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,059,690 - Ciblat , et al. August 28, 2 | 2018-08-28 |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) Grant 10,047,070 - Gray , et al. August 14, 2 | 2018-08-14 |
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20180208578 - Ciblat; Stephane ;   et al. | 2018-07-26 |
Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20170183355 - Sprott; Kevin ;   et al. | 2017-06-29 |
Heteroaromatic Compounds Useful For The Treatment Of Prolferative Diseases App 20160264551 - Ciblat; Stephane ;   et al. | 2016-09-15 |
Heteromaromatic Compounds Useful For The Treatment Of Prolferative Diseases App 20160264552 - Ciblat; Stephane ;   et al. | 2016-09-15 |
Polycyclic Inhibitors Of Cyclin-dependent Kinase 7 (cdk7) App 20160264554 - Gray; Nathanael ;   et al. | 2016-09-15 |
Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors Grant 9,227,971 - Siddiqui , et al. January 5, 2 | 2016-01-05 |
Anilinopiperazine derivatives and methods of use thereof Grant 9,206,142 - Shipps, Jr. , et al. December 8, 2 | 2015-12-08 |
Fused tricyclic inhibitors of mammalian target of rapamycin Grant 8,927,562 - Meng , et al. January 6, 2 | 2015-01-06 |
Therapeutic Compounds And Related Methods Of Use App 20140371285 - Sprott; Kevin ;   et al. | 2014-12-18 |
Fused tricyclic compounds as mTOR inhibitors Grant 8,901,142 - Meng , et al. December 2, 2 | 2014-12-02 |
Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors Grant 8,883,801 - Zhao , et al. November 11, 2 | 2014-11-11 |
Heterocyclic Compounds As B-raf Inhibitors For Treatment Of Cancer App 20140323519 - Siddiqui; M. Arshad ;   et al. | 2014-10-30 |
Compounds for inhibiting KSP kinesin activity Grant 8,796,460 - Siddiqui , et al. August 5, 2 | 2014-08-05 |
Substituted pyrazolo[1,5-a]pyrido[3.2-e]pyrimidin-6-one inhibitors of mammalian target of rapamycin Grant 8,703,784 - Meng , et al. April 22, 2 | 2014-04-22 |
Heterocyclic amide compounds as protein kinase inhibitors Grant 8,669,259 - Reddy , et al. March 11, 2 | 2014-03-11 |
Fused Tricyclic Compounds as novel mTOR inhibitors Grant 8,609,675 - Cheng , et al. December 17, 2 | 2013-12-17 |
Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors Grant 8,591,943 - Deng , et al. November 26, 2 | 2013-11-26 |
Compounds for the treatment of inflammatory disorders Grant 8,569,336 - Tong , et al. October 29, 2 | 2013-10-29 |
Fused Tricyclic Inhibitors Of Mammalian Target Of Rapamycin App 20130281474 - Meng; Zhaoyang ;   et al. | 2013-10-24 |
Compounds that are ERK inhibitors Grant 8,546,404 - Cooper , et al. October 1, 2 | 2013-10-01 |
Compounds for the treatment of inflammatory disorders Grant 8,541,572 - Kozlowski , et al. September 24, 2 | 2013-09-24 |
Thiazole Derivatives as protein kinase inhibitors Grant 8,476,278 - Reddy , et al. July 2, 2 | 2013-07-02 |
NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS App 20130150362 - Zhao; Lianyun ;   et al. | 2013-06-13 |
Fused Tricyclic Inhibitors of Mammalian Target of Rapamycin App 20130150353 - Meng; Zhaoyang ;   et al. | 2013-06-13 |
Anilinopiperazine Derivatives And Methods Of Use Thereof App 20120328691 - Shipps, JR.; Gerald W. ;   et al. | 2012-12-27 |
PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS App 20120322791 - Siddiqui; M. Arshad ;   et al. | 2012-12-20 |
2-aminothiazole-4-carboxylic amides as protein kinase inhibitors Grant 8,318,735 - Shipps, Jr. , et al. November 27, 2 | 2012-11-27 |
Heterocyclic amide compounds as protein kinase inhibitors Grant 8,293,747 - Reddy , et al. October 23, 2 | 2012-10-23 |
Substituted pyridines that are JNK inhibitors Grant 8,278,337 - Belanger , et al. October 2, 2 | 2012-10-02 |
Heterocyclic Amide Compounds As Protein Kinase Inhibitors App 20120208826 - Reddy; Panduranga Adulla P. ;   et al. | 2012-08-16 |
FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS App 20120178744 - Cheng; Cliff C. ;   et al. | 2012-07-12 |
Compounds for the treatment of inflammatory disorders Grant 8,178,553 - Lavey , et al. May 15, 2 | 2012-05-15 |
Spiro 1,3,4-thiadiazoline Derivatives As Ksp Inhibitors App 20120070370 - Siddiqui; M. Arshad ;   et al. | 2012-03-22 |
Compounds For The Treatment Of Inflammatory Disorders App 20120015926 - Tong; Ling ;   et al. | 2012-01-19 |
Compounds For The Treatment Of Inflammatory Disorders App 20120010181 - Kozlowski; Joseph A. ;   et al. | 2012-01-12 |
Synthesis And Use Of Heterocyclic Antibacterial Agents App 20110212078 - Reddy; Panduranga Adulla P. ;   et al. | 2011-09-01 |
Urea Derivatives As Antibacterial Agents App 20110212080 - Mansoor; Umar Faruk ;   et al. | 2011-09-01 |
Hydantoin derivatives useful as antibacterial agents Grant 7,998,961 - Mansoor , et al. August 16, 2 | 2011-08-16 |
Compounds For Inhibiting Ksp Kinesin Activity App 20110171172 - Siddiqui; M. Arshad ;   et al. | 2011-07-14 |
Compounds For Inhibiting Ksp Kinesin Activity App 20110150757 - Siddiqui; M. Arshad ;   et al. | 2011-06-23 |
Heterocyclic Urea and Thiourea Derivatives and Methods of Use Thereof App 20110129440 - Tadikonda; Praveen K. ;   et al. | 2011-06-02 |
Compounds For Inhibiting Ksp Kinesin Activity App 20110123435 - Siddiqui; M. Arshad ;   et al. | 2011-05-26 |
Compounds for the treatment of inflammatory disorders Grant 7,879,890 - Yu , et al. February 1, 2 | 2011-02-01 |
Thiazole Derivatives as Protein Kinase Inhibitors App 20100331313 - Reddy; Panduranga Adulla P. ;   et al. | 2010-12-30 |
Novel Jnk Inhibitors App 20100298314 - Reddy; Panduranga Adulla P. ;   et al. | 2010-11-25 |
Heterocyclic Amide Compounds As Protein Kinase Inhibitors App 20100286135 - Reddy; Panduranga Adulla P. ;   et al. | 2010-11-11 |
Compounds that are ERK inhibitors Grant 7,807,672 - Deng , et al. October 5, 2 | 2010-10-05 |
Compounds for the treatment of inflammatory disorders Grant 7,772,263 - Lavey , et al. August 10, 2 | 2010-08-10 |
Novel Jnk Inhibitors App 20100179141 - Belanger; David B. ;   et al. | 2010-07-15 |
Compounds For The Treatment Of Inflammatory Disorders App 20100145048 - Guo; Zhuyan ;   et al. | 2010-06-10 |
2-aminothiazole-4-carboxylic Amides As Protein Kinase Inhibitors App 20100130465 - Shipps, JR.; Gerald W. ;   et al. | 2010-05-27 |
Compounds For The Treatment Of Inflammatory Disorders App 20100120838 - Lavey; Brian J. ;   et al. | 2010-05-13 |
Compounds for the treatment of inflammatory disorders Grant 7,687,527 - Yu , et al. March 30, 2 | 2010-03-30 |
Compounds for the treatment of inflammatory disorders Grant 7,683,088 - Lavey , et al. March 23, 2 | 2010-03-23 |
Compounds for the treatment of inflammatory disorders Grant 7,652,020 - Guo , et al. January 26, 2 | 2010-01-26 |
Compounds for the treatment of inflammatory disorders Grant 7,638,513 - Siddiqui , et al. December 29, 2 | 2009-12-29 |
Imidazopyrazines as cyclin dependent kinase inhibitors Grant 7,576,085 - Guzi , et al. August 18, 2 | 2009-08-18 |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors Grant 7,563,798 - Guzi , et al. July 21, 2 | 2009-07-21 |
Imidazopyrazines As Protein Kinase Inhibitors App 20090175852 - Ciavarri; Jeffrey P. ;   et al. | 2009-07-09 |
Imidazopyrazines as protein kinase inhibitors Grant 7,557,104 - Zhao , et al. July 7, 2 | 2009-07-07 |
Compounds For The Treatment Of Inflammatory Disorders App 20090170875 - Yu; Wensheng ;   et al. | 2009-07-02 |
Compounds for the treatment of inflammatory disorders and microbial diseases Grant 7,553,864 - Siddiqui , et al. June 30, 2 | 2009-06-30 |
Compounds For The Treatment Of Inflammatory Disorders App 20090156586 - Lavey; Brian J. ;   et al. | 2009-06-18 |
Compounds For The Treatment Of Inflammatory Disorders App 20090137586 - Yu; Wensheng ;   et al. | 2009-05-28 |
Novel compounds that are ERK inhibitors App 20090118284 - Cooper; Alan B. ;   et al. | 2009-05-07 |
Compounds for the treatment of inflammatory disorders Grant 7,524,842 - Lavey , et al. April 28, 2 | 2009-04-28 |
High affinity quinoline-based kinase ligands Grant 7,511,063 - Deng , et al. March 31, 2 | 2009-03-31 |
Imidazopyrazines as protein kinase inhibitors Grant 7,511,040 - Belanger , et al. March 31, 2 | 2009-03-31 |
Compounds for the treatment of inflammatory disorders Grant 7,504,424 - Yu , et al. March 17, 2 | 2009-03-17 |
Compounds for the treatment of inflammatory disorders Grant 7,488,745 - Yu , et al. February 10, 2 | 2009-02-10 |
High affinity thiophene-based and furan-based kinase ligands Grant 7,446,195 - Deng , et al. November 4, 2 | 2008-11-04 |
Hydantoin Derivatives Useful As Antibacterial Agents App 20080226618 - Mansoor; Umar Faruk ;   et al. | 2008-09-18 |
Imidazopyrazines As Protein Kinase Inhibitors App 20080139571 - Belanger; David B. ;   et al. | 2008-06-12 |
Heterocyclic Kinase Inhibitors: Methods of Use and Synthesis App 20080119515 - Siddiqui; M Arshad ;   et al. | 2008-05-22 |
Novel high affinity quinoline-based kinase ligands App 20080045568 - Deng; Yongqi ;   et al. | 2008-02-21 |
Imidazopyrazines As Protein Kinase Inhibitors App 20080027063 - Zhao; Lianyun ;   et al. | 2008-01-31 |
Compounds for the treatment of inflammatory disorders App 20070265299 - Lavey; Brian J. ;   et al. | 2007-11-15 |
Novel compounds that are ERK inhibitors App 20070232610 - Deng; Yongqi ;   et al. | 2007-10-04 |
Compounds for the treatment of inflammatory disorders App 20070219218 - Yu; Wensheng ;   et al. | 2007-09-20 |
Compounds for the treatment of inflammatory disorders App 20070197564 - Lavey; Brian J. ;   et al. | 2007-08-23 |
Novel compounds that are ERK inhibitors App 20070191604 - Cooper; Alan ;   et al. | 2007-08-16 |
Compounds for the treatment of inflammatory disorders and microbial diseases App 20070167426 - Siddiqui; M. Arshad ;   et al. | 2007-07-19 |
Compounds for the treatment of inflammatory disorders and microbial diseases App 20070129378 - Siddiqui; M. Arshad ;   et al. | 2007-06-07 |
Imidazopyrazines as protein kinase inhibitors App 20070117804 - Zhao; Lianyun ;   et al. | 2007-05-24 |
Methods for inhibiting protein kinases App 20070105864 - Guzi; Timothy J. ;   et al. | 2007-05-10 |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors App 20070072882 - Guzi; Timothy J. ;   et al. | 2007-03-29 |
Novel high affinity thiophene-based and furan-based kinase ligands App 20070043045 - Deng; Yongqi ;   et al. | 2007-02-22 |
Compounds for the treatment of inflammatory disorders App 20060276506 - Yu; Wensheng ;   et al. | 2006-12-07 |
Compounds for the treatment of inflammatory disorders App 20060252778 - Guo; Zhuyan ;   et al. | 2006-11-09 |
Compounds for the treatment of inflammatory disorders App 20060178366 - Siddiqui; M. Arshad ;   et al. | 2006-08-10 |
Novel imidazopyrazines as cyclin dependent kinase inhibitors App 20060106023 - Guzi; Timothy J. ;   et al. | 2006-05-18 |
Low molecular weight bicyclic thrombin inhibitors Grant 6,057,314 - Dimaio , et al. May 2, 2 | 2000-05-02 |
Stereoselective synthesis of nucleoside analogues using bicyclic intermediate Grant 5,763,606 - Mansour , et al. June 9, 1 | 1998-06-09 |
Processes for the diastereoselective synthesis of nucleoside analogues Grant 5,696,254 - Mansour , et al. December 9, 1 | 1997-12-09 |
Processes for the diastereoselective separation of nucleoside analogue synthetic intermediates Grant 5,663,320 - Mansour , et al. September 2, 1 | 1997-09-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.